Document is current
Any future updates will be listed below
-
Authors
Podrascanin, Vanja
Ammann, Markus
Gudmundsdottir, Hallbera
Dong, Yawen
Thiels, Cornelius A.
Warner, Susanne G.
Truty, Mark J.
Kendrick, Michael L.
Smoot, Rory L.
Pommier, Rodney F.
Kozuma, Kaiya
Halfdanarson, Thorvardur R.
Nagorney, David M.
Starlinger, Patrick P.
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 20 November 2025
First Online: 9 December 2025
Disclosures
: Thorvardur R. Halfdanarson served on the consulting/advisory board for Ipsen, Curium, Advanced Accelerator Applications (a Novartis company), ITM Isotopen Technologien Muenchen, Exelixis, Boehringer-Ingelheim, Biomea Fusion, and Crinetics. Dr. Halfdanarson received research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Camurus, Crinetics, ITM Isotopen Technologien Muenchen, and Perspective Therapeutics. The remaining authors have no conflicts of interest.
